Akari Therapeutics, Plc (AKTX) NASDAQ
14.63
+1.2(+8.94%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
14.63
+1.2(+8.94%)
Currency In USD
| Market Cap | 243,222.4 |
| Enterprise Value | -4.21M |
| P/E Ratio | -0.01 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.02 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.51 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.83 |
| Return On Equity | -1.23 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -17.35M |
| Net Income | -17.3M |
| Diluted EPS | -20,800 |
| Total Cash | 2.77M |
| Total Cash/Share | 131.56 |
| Total Debt | 732,000 |
| Total Debt/Equity | 0.05 |
| Current Ratio | 0.27 |
| Book Value Per Share | 683.46 |
| 52-Week Change | -72.71 |
| 52-Week High | 55.6 |
| 52-Week Low | 3.02 |
| Moving Average 50 Days | 6.6 |
| Moving Average 200 Days | 17.28 |
| Average Volume | 763,180 |
| Shares Outstanding | 1.14M |
| % Held by Institutions | 0.2 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
| Last Split Date | March 31, 2026 |